Attenuating the mortality risk of High serum uric acid: The role of physical activity underused

Annals of the Rheumatic Diseases

Volumn 74, Issue 11, 2015, Pages 2034-2042

  Chen, Jiunn Horng ^a,b   Wen, Chi Pang ^a,c   Wu, Shiuan Bei ^c   Lan, Joung Liang ^a,b   Tsai, Min Kuang ^c   Tai, Ya Ping ^c   Lee, June Han ^c   Hsu, Chih Cheng ^c   Tsao, Chwen Keng ^d   Wai, Jackson Pui Man ^e   Chiang, Po Huang ^c,f   Pan, Wen Han ^c   Hsiung, Chao Agnes ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d MJ Health Management Institution   (Taiwan)

^e NATIONAL TAIWAN SPORT UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERURICEMIA; LEISURE; LIFE EXPECTANCY; LIFE EXTENSION; LIFESTYLE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL HISTORY; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; RISK REDUCTION; SELF REPORT; URIC ACID BLOOD LEVEL; ASYMPTOMATIC DISEASE; BLOOD; CAUSE OF DEATH; DIABETES MELLITUS; EXERCISE; HYPERLIPIDEMIAS; HYPERTENSION; MIDDLE AGED; MOTOR ACTIVITY; PREDIABETIC STATE; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; SEDENTARY LIFESTYLE; SMOKING; TAIWAN; YOUNG ADULT;

URIC ACID;

ADULT; AGED; ASYMPTOMATIC DISEASES; CAUSE OF DEATH; COHORT STUDIES; DIABETES MELLITUS; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPERURICEMIA; LEISURE ACTIVITIES; MALE; MIDDLE AGED; MORTALITY; MOTOR ACTIVITY; PREDIABETIC STATE; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEDENTARY LIFESTYLE; SMOKING; TAIWAN; URIC ACID; YOUNG ADULT;

EID: 84945187095     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205312     Document Type: Article

References (45)

1. Wen CP, David Cheng TY, Chan HT, et al. Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis 2010;56:273-88.
2. Jeemon P, Prabhakaran D. Does uric acid qualify as an independent risk factor for cardiovascular mortality? Clin Sci (Lond) 2013;124:255-7.
3. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010;62:170-80.
4. Okura T, Higaki J, Kurata M, et al. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 2009;73:885-91.
5. Chen JH, Chuang SY, Chen HJ, et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009;61:225-32.
6. Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006;37:1503-7.
7. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-51.
8. Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002;89:12-7.
9. Ndrepepa G, Braun S, King L, et al. Uric acid and prognosis in angiography-proven coronary artery disease. Eur J Clin Invest 2013;43:256-66.
10. Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 2000;10:403-9.
11. Liese AD, Hense HW, Lowel H, et al. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999;10:391-7.
12. Pluta RM, Shmerling RH, Burke AE, et al. JAMA patient page. Gout JAMA 2012;308:2161.
13. Skak-Nielsen H, Torp-Pedersen C, Finer N, et al. Uric Acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One 2013;8:e59121.
14. Wheeler JG, Juzwishin KD, Eiriksdottir G, et al. Serum uric acid and coronary heart disease in 9458 incident cases and 1 55 084 controls: prospective study and meta-analysis. PLoS Med 2005;2:e76.
15. Jee SH, Lee SY, Kim MT. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil 2004;11:185-91.
16. Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999;131:7-13.
17. Halevy S, Ghislain PD, Mockenhaupt M, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008;58:25-32.
18. Gutierrez-Macias A, Lizarralde-Palacios E, Martinez-Odriozola P, et al. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 2005;331:623-4.
19. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120:442-7.
20. Feig DI, Mazzali M, Kang DH, et al. Serum uric acid: a risk factor and a target for treatment? J Am Soc Nephrol 2006;17 (4 Suppl 2):S69-73.
21. Reimers CD, Knapp G, Reimers AK. Does physical activity increase life expectancy? A review of the literature. J Aging Res 2012;2012:243958.
22. Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 2011;378:1244-53.
23. WHO. Global Recommendations on physical activity for health, 2010.
24. U. S. Department of Health and Human Services. 2008 Physical Activity Guidelinies for Americans. Washington, DC, 2008.
25. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371:2173-82.
26. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32 (9 Suppl):S498-504.
27. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
28. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39 (2 Suppl 1):S1-266.
29. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
30. Wen CP, Lin J, Yang YC, et al. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases. J Natl Cancer Inst 2012;104:1599-611.
31. Gochman N, Schmitz JM. Automated determination of uric acid, with use of a uricase-peroxidase system. Clin Chem 1971;17:1154-9.
32. Wen CP, Tsai SP, Chung WS. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 2008;148:258-67.
33. Chiang CL. The Life Table and Its Applications, Robert E Krieger, 1984.
34. Green HJ, Fraser IG. Differential effects of exercise intensity on serum uric acid concentration. Med Sci Sports Exerc 1988;20:55-9.
35. Iliesiu A, Campeanu A, Dusceac D. Serum uric acid and cardiovascular disease. Maedica (Buchar) 2010;5:186-92.
36. Lippi G, Montagnana M, Franchini M, et al. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 2008;392:1-7.
37. Nishida Y, Iyadomi M, Higaki Y, et al. Influence of physical activity intensity and aerobic fitness on the anthropometric index and serum uric acid concentration in people with obesity. Intern Med 2011;50:2121-8.
38. Xiong Z, Zhu C, Qian X, et al. Serum uric acid is associated with dietary and lifestyle factors in elderly women in suburban Guangzhou in Guangdong province of south China. J Nutr Health Aging 2013;17:30-4.
39. Nan H, Qiao Q, Dong Y, et al. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 2006;33:1346-50.
40. Lee MS, Lin SC, Chang HY, et al. High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr 2005;14:285-92.
41. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004;4:9.
42. Chang HY, Pan WH, Yeh WT, et al. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001;28:1640-6.
43. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63:3136-41.
44. Chen JH, Pan WH, Hsu CC, et al. Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study. Arthritis Care Res (Hoboken) 2013;65:133-40.
45. Chen JH, Yeh WT, Chuang SY, et al. Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol 2012;31:239-45.